Life Science Software - 2013 Market Report: Markets and Opportunities

DUBLIN, August 7, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/3t8m5h/life_science) have announced the addition of the "Life Science Software 2013: Markets and Opportunities" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Biopharm Reports has carried out six studies in the life science field, which examined the use of specialist software and databases relating to the conduct of PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarker studies. These studies, which involved the participation of more than 2,200 end-users in 70 countries, were carried out to assist software developers and vendors to identify market opportunities in these fields.

Biopharm Reports has published a new report on the use of software and databases in the life science field. This is the outcome of six global studies involving more than 2,200 end-users in the PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker fields. These findings provide substantial information on end-user practices and opportunities in these markets.

This Report Provides:

- Software and Databases: A breakdown of end-user practices in the use of software and databases (including software/database market brands or in-house) in the conduct of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies.

- Fields: A breakdown of end-user practices in the use of software and databases (including software/database market brands or in-house) by field (biotechnology, chemicals, clinical or hospital, defence, diagnostics, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and university) in the conduct of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies.

- Regions: A breakdown of end-user practices in the use of software and databases (including software/database market brands or in-house) by regions (Europe, North America, Asia and Rest of World) in the conduct of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies.

- Growth: A listing of organisations of participants in the PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies described in this report, according to their anticipated growth in these areas, (i.e. decline in activities, activities remain the same or increase in activities).

- Market Sizes: Estimates of global markets sizes of software and databases used in the PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker fields. These estimates are based on published market sizes of these fields, and the present study findings described in this report.

Key Areas

- PCR (Participants, n=614)
- DNA Microarray (Participants, n=201)
- DNA Sequencing (Participants, n=108)
- Flow Cytometry (Participants, n=262)
- Mass Spectrometry (Participants, n=567)
- Disease Biomarkers (Participants n=511)
- Participant Organisations
- Organisation Growth Trends

Key Topics Covered:

1 Background
2 This Study
3 Polymerase Chain Reaction (PCR)
4 DNA Microarray
5 DNA Sequencing
6 Flow Cytometry
7 Mass Spectrometry
8 Disease Biomarkers
9 Conclusions

For more information visit http://www.researchandmarkets.com/research/3t8m5h/life_science

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology

SOURCE Research and Markets